WO2020180067A1 - Rapid-freezing storage device for tissue and rapid-freezing storage method for tissue - Google Patents

Rapid-freezing storage device for tissue and rapid-freezing storage method for tissue Download PDF

Info

Publication number
WO2020180067A1
WO2020180067A1 PCT/KR2020/002948 KR2020002948W WO2020180067A1 WO 2020180067 A1 WO2020180067 A1 WO 2020180067A1 KR 2020002948 W KR2020002948 W KR 2020002948W WO 2020180067 A1 WO2020180067 A1 WO 2020180067A1
Authority
WO
WIPO (PCT)
Prior art keywords
tissue
storage
liquid nitrogen
case
storage case
Prior art date
Application number
PCT/KR2020/002948
Other languages
French (fr)
Korean (ko)
Inventor
이상훈
이장우
김보람
Original Assignee
고려대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 고려대학교 산학협력단 filed Critical 고려대학교 산학협력단
Publication of WO2020180067A1 publication Critical patent/WO2020180067A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0236Mechanical aspects
    • A01N1/0242Apparatuses, i.e. devices used in the process of preservation of living parts, such as pumps, refrigeration devices or any other devices featuring moving parts and/or temperature controlling components
    • A01N1/0252Temperature controlling refrigerating apparatus, i.e. devices used to actively control the temperature of a designated internal volume, e.g. refrigerators, freeze-drying apparatus or liquid nitrogen baths
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D43/00Lids or covers for rigid or semi-rigid containers
    • B65D43/02Removable lids or covers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/18Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient

Definitions

  • the present invention relates to a rapid freezing storage device for tissues and a method for storing rapid freezing tissues, and in detail, the process of vitrifying tissue and sealing the vitrified tissue is continuously carried out inside the liquid nitrogen communication system to seal the vitrified tissue.
  • the present invention relates to a rapid freezing storage device for tissues and a rapid freezing storage method for tissues capable of preventing damage to tissues due to a temperature difference between the temperature of the vitrified tissues and room temperature that may occur during the process.
  • reproductive cells After fertilization in the mother's womb, reproductive cells develop in the egg yolk of the fetus and move into the fetus. In the case of women, they differentiate into ovaries through the process of componentization. The eggs created during this period are held in the ovary in a state of being stopped at the beginning of the first meiosis phase.
  • Freezing methods for preserving fertility in female cancer patients include embryo freezing, egg automatic freezing, and ovarian tissue freezing. The selection of the most appropriate method among these depends on the timing and drug of chemotherapy, the type of cancer, the age of the patient and the presence of a spouse.
  • cryopreservation of embryos and eggs is an impossible method in women who cannot delay treatment to induce superovulation.
  • cryopreservation of the ovaries is possible in all women, including children before puberty and women who cannot delay chemotherapy.
  • the main goal of ovarian tissue freezing is to implant cryopreserved ovarian tissue in the orthotopic site or at a heterotopic site, such as the upper arm or abdominal wall, when the patient is healed or the disease has been treated.
  • cryoprotective agent CPA
  • Vitrification freezing is a process in which ovarian tissue is immersed in liquid nitrogen and rapidly cooled to -180°C.
  • Vitrification freezing requires tissues to be placed in liquid nitrogen within a very short period of time, so the most suitable tool for this procedure is required.
  • tools such as Kitazato's Cryotop TM and CooperSurgical's Cryoleaf TM are used.
  • Kitazato product which is one of the products used for vitrification
  • a tissue for cryopreservation is prepared.
  • the tissue is contained in a vitrification media. This vitrification media treatment is for preventing moisture from escaping from the tissue.
  • the media-treated tissue for vitrification is placed in a kit. Then, the tissue placed in the kit is inserted into the liquid nitrogen communication system, and the process of vitrification by the liquid nitrogen proceeds.
  • the kit comes out of the liquid nitrogen cylinder at -180°C and at room temperature, the kit is sealed in a case containing liquid nitrogen as shown in FIG. 1(d).
  • ovarian tissue freezing is to transplant cryopreserved ovarian tissue into the pelvis (orthotopic site) or at a heterotopic site such as the upper arm or abdominal wall when the patient is cured or the disease is over.
  • Ovarian tissue has a problem that cannot be used for transplantation.
  • Patent Document 1 Japanese Patent No. 5825571 discloses a cryopreservation tool for cryopreserving a biological sample.
  • the process of vitrifying the tissue and the process of sealing the vitrified tissue are continuously carried out inside the liquid nitrogen communication, and damage to the tissue due to the temperature difference between the temperature of the vitrified tissue and room temperature that can occur in the process of sealing the vitrified tissue.
  • the purpose of this study is to provide a quick-freezing storage device for tissues and a rapid-freezing storage method for tissues.
  • a tissue fast-freezing storage device has a cylindrical shape with an open top, and a tissue seating portion on which the tissue is placed; And a storage case with an open top and a tissue seat, a storage lid that seals the internal space of the storage case, and the storage lid is moved up and down with respect to the storage case so that the storage lid is coupled to the storage case.
  • It includes a tissue storage unit including an operation member for manipulating the movement of the storage lid, wherein the tissue is placed on the tissue seating unit and is vitrified by liquid nitrogen in the liquid nitrogen communication unit, and the vitrified tissue is the tissue seating unit in the liquid nitrogen communication unit.
  • the tissue storage unit is connected to the storage case and the storage lid sealing the inner space of the storage case and the storage case and the storage lid, the storage case having an open top and a tissue seat
  • the storage lid is coupled to the storage case and includes an operation member operated to seal the internal space, and the tissue storage unit is mounted in the storage case so that the tissue is immersed in the liquid nitrogen in the liquid nitrogen communication unit, It is preferable that the storage lid is operated to be coupled to the storage case by the operation member, so that the tissue seating portion is sealed in the inner space of the storage case.
  • the tissue storage unit further includes a case holder on which the storage case is mounted, and a lid holder on which the case holder is placed facing the case holder and on which the storage lid is mounted, and an operation member It is preferable to connect the lid holder and the case holder to manipulate the gap between the case holder and the lid holder.
  • the tissue seating portion is made of a mesh net, and before the tissue is vitrified, when chemically treated by the vitrification media, the tissue mounting portion is in a state in which the tissue is seated, and the vitrification media is It is preferable that it is inserted into the contained medicine container and contained in the vitrification media for chemical treatment.
  • the bottom surface of the tissue seating portion is made of a material having high thermal conductivity.
  • the method for storing the tissue for rapid freezing comprises the steps of: (A) the tissue is placed on the tissue seating unit, and is treated with a drug by a vitrification media; (B) a step in which the tissue seating portion is inserted into the liquid nitrogen communication and the tissue is rapidly frozen and vitrified by the liquid nitrogen in the liquid nitrogen communication; (C) the tissue storage unit including the storage case, the storage lid and the operation member is inserted into the interior of the liquid nitrogen communication, and the liquid nitrogen is contained in the storage case; (D) the tissue seating portion is inserted into the storage case and mounted, so that the tissue is immersed in liquid nitrogen in the inner space of the storage case; (E) the storage lid is operated to be coupled to the storage case by the operation member, and sealing the tissue in a state immersed in liquid nitrogen in the internal space; And (F) the tissue storage unit in a state in which cold air is maintained by the liquid nitrogen in the storage case, comes out of the liquid nitrogen communication and is inserted into the freezing storage tank, and
  • steps B to E are sequentially performed in liquid nitrogen communication.
  • step F it is preferable that the tissue storage unit is seated in a dipper mounted on a freezing storage tank and positioned so as to be immersed in liquid nitrogen in the freezing storage tank.
  • the vitrification process of the tissue and the process of sealing the vitrified tissue are continuously performed inside the liquid nitrogen communication system, and the vitrified tissue, which can occur during the process of sealing the existing vitrified tissue in a container containing liquid nitrogen at room temperature. It is possible to prevent damage to the tissue caused by the temperature difference between the temperature and the temperature at which the tissue is sealed.
  • the present invention prevents tissue damage during the process of freezing and sealing the tissue, and after chemotherapy, it is possible to increase the success rate of tissue transplantation using the thawed tissue.
  • the present invention eliminates the process of transferring the drug-treated tissue by the vitrification media to the kit used for vitrification of the tissue compared to the prior art by being chemically treated by the vitrification media while the tissue is placed on the tissue seat. Thus, it is possible to improve the work efficiency of the pretreatment process before freezing the tissue.
  • the present invention allows the storage lid to be coupled to the storage case with only a simple operation of the operating member, so that the tissue is sealed in the storage case containing liquid nitrogen, so that the operator can remove the vitrified tissue without contacting the storage case, which is a part containing liquid nitrogen. It can be sealed in the tissue storage area.
  • FIG. 1 is a view for explaining a tissue freezing method according to the prior art.
  • FIG. 2 is a schematic diagram showing the configuration of a tissue storage device for rapid freezing according to an embodiment of the present invention.
  • 3 and 4 are views for explaining a process in which the tissue seating unit is sealed to the tissue storage unit.
  • FIG. 5 is a view for explaining a tissue storage unit according to another example.
  • Figure 6 is a view for explaining the process of the inventors of the rapid freezing storage device of the tissue is inserted into a freezing storage tank, frozen storage.
  • a tissue fast-freezing storage device has a cylindrical shape with an open top, and a tissue seating portion on which the tissue is placed; And a storage case with an open top and a tissue seat, a storage lid that seals the internal space of the storage case, and the storage lid is moved up and down with respect to the storage case so that the storage lid is coupled to the storage case.
  • It includes a tissue storage unit including an operation member for manipulating the movement of the storage lid, wherein the tissue is placed on the tissue seating unit and is vitrified by liquid nitrogen in the liquid nitrogen communication unit, and the vitrified tissue is the tissue seating unit in the liquid nitrogen communication unit.
  • a tissue storage device for rapid freezing of a tissue is for storing tissue that is rapidly cooled and vitrified.
  • the tissue was obtained from the human body before chemotherapy, and is intended to be transplanted back into the human body after chemotherapy. In order for the tissue transplanted into the human body to achieve the desired effect, the tissue must not be deformed during the tissue storage process.
  • the process of vitrifying the tissue and sealing the tissue to the tissue storage unit proceeds continuously within the liquid nitrogen communication unit, thereby sealing the vitrified tissue to the tissue storage unit together with liquid nitrogen. Thereafter, the tissue storage unit in which the tissue is sealed comes out of the liquid nitrogen communication and is then stored in a freezing storage tank.
  • the freezing storage tank is a tank containing liquid nitrogen.
  • the tissue storage device for rapid freezing 100 includes a tissue storage unit 110 and a tissue seating unit 130.
  • the tissue seating portion 130 has a cylindrical shape with an open top.
  • the tissue seating unit 130 is placed on the tissue 150 on the bottom surface.
  • the tissue seating unit 130 may have a bottom surface made of a mesh network, so that the tissue 150 is placed on the tissue seating unit 130 to be treated with chemicals by the vitrification media.
  • the tissue 150 is vitrified while being rapidly cooled by liquid nitrogen in a state seated on the tissue mounting portion 130.
  • the bottom surface of the tissue seating unit 130 is made of a material having a high thermal conductivity, so that the rapid cooling efficiency of the tissue by liquid nitrogen may be increased.
  • the material having high thermal conductivity any one of silver, copper, aluminum, stainless steel, aluminum nitride, silicon nitride, alumina, metal powder, aluminum nitride, and the like may be selected.
  • a handle 131 is provided on the upper end of the tissue seating part 130. This is, in the process of vitrifying the tissue 150, in the process of vitrifying the tissue 150, while the operator stably holds the tissue seat 130, gently shake the tissue seat 130 in a state immersed in liquid nitrogen. While it is possible to promote the vitrification of the tissue 150 more smoothly. In addition, by preventing the operator from contacting the liquid nitrogen, it is possible to prevent the operator from being injured by the liquid nitrogen during the vitrification process of the tissue 150.
  • the handle 131 can be removed from the tissue mounting portion 130 in the process of sealing the tissue mounting portion 130 to the tissue storage portion.
  • the tissue seating unit 130 is inserted into the storage case 114 of the tissue storage unit 110.
  • the tissue seating portion 130 is mounted on the storage case 114 so that the upper end of the tissue seating portion 130 is caught on the upper end of the storage case 114 and the bottom surface of the tissue seating portion 130 is spaced apart from the bottom surface of the storage case 114.
  • liquid nitrogen is contained in the storage case 114.
  • the tissue seating unit 130 is sealed in the inner space of the tissue storage unit 110 while the storage case 114 and the storage lid 115 are assembled with each other by the manipulation of the operation member 113.
  • the tissue storage unit 110 is composed of a case holder 111, a lid holder 112, a storage case 114, a storage lid 115, and an operation member 113.
  • the tissue storage unit 110 is a container for freezing the vitrified tissue 150.
  • the vitrified tissue 150 is sealed and stored in the tissue storage unit 110 in a state placed on the tissue seating unit 130. At this time, the vitrified tissue 150 is stored in the tissue storage unit 110 in a state immersed in liquid nitrogen stored in the storage case 114.
  • the storage case 114 has a cylindrical shape with an open top.
  • the storage case 114 is a container in which the tissue seating unit 130 is mounted.
  • the storage case 114 is manufactured in a size in which the tissue seating portion 130 is inserted into the inner space and can be mounted. When the storage case 114 is combined with the storage lid 115, the inner space is sealed.
  • the storage case 114 contains liquid nitrogen.
  • the storage case 114 is provided with a plurality of openings 114a.
  • the plurality of openings 114a are passages through which liquid nitrogen vaporized in the internal space of the storage case 114 exits to the outside of the storage case 114.
  • the storage case 114 is sealed by the storage lid 115, and then the liquid nitrogen is vaporized and the storage case 114 ), the pressure in the inner space of the inner space is increased, so that the storage lid 115 can be prevented from being separated from the storage case 114.
  • the storage case 114 is detachably installed on the case holder 111.
  • the storage lid 115 is detachably installed on the lid holder 112.
  • the case holder 111 and the lid holder 112 are connected to each other by an operation member 113.
  • the present invention (100a) is a tissue storage unit (110a) without a case holder 111 and/or a lid holder 112, the storage case 114 and the storage lid ( 115) may be directly installed on the operation member 113.
  • the operating member 113 is composed of a first operating member (113a) and a second operating member (113b).
  • the first operation member 113a is installed to protrude upward from the side of the case holder 111.
  • a first handle 113a1 is provided on an upper end of the first manipulation member 113a.
  • a dipper hanger 113a2 is provided on the upper end of the first manipulation member 113a.
  • the dipper hook portion 113a2 is a ring provided so that the tissue storage portion 110 is caught on the dipper 170.
  • the operator holds the first handle (113a1) and / or the second handle (113b1) provided on the top of the operation member 113, as if a ladle scoops the soup in a soup pot, and only the portion of the storage case 114 is liquefied nitrogen communication 160 ), and put the liquid nitrogen in the storage case 114.
  • the storage lid 115 is connected to the second operation member 113b. At this time, the storage lid 115 is located above the storage case 114.
  • a second handle 113b1 is provided on the upper end of the second manipulation member 113b.
  • the second manipulation member 113b is coupled to the first manipulation member 113a so as to be movable up and down with respect to the first manipulation member 113a.
  • the first manipulating member 113a is provided with a guide groove 113a3
  • the second manipulating member 113b is provided with a locking protrusion 113b2 that can move up and down along the guide groove 113a3.
  • the tissue storage case 114 Can be combined or separated. Accordingly, the present invention can prevent an image caused by contact with liquid nitrogen, which is generated in the process of sealing the tissue seating unit 130 to the storage case 114 in which liquid nitrogen is stored.
  • the tissue seating unit 130 may have a bottom surface made of a mesh network, so that the tissue 150 is placed on the tissue seating unit 130 to be treated with chemicals by the vitrification media.
  • the present invention can improve the work efficiency of the pretreatment process prior to freezing of the tissue 150 by omitting the process of transferring the tissue 150 treated by the vitrification media to the kit.
  • the permeable cryoprotectant lowers the glass transition temperature of the solution, thus preventing the solution from being actually frozen, and inducing a fatal stress due to ice formation in the cells.
  • buffers carbohydrates (e.g., glucose, lactose, raffinose, sucrose and trehalose), salts (sodium citrate) (sodium citrate), citric acid), egg yolk and antibiotics permeable cryoprotectant glycerol.
  • the osmotic pressure is balanced to protect the plasma membrane and the mitochondrial membrane from damage, and to prevent DNA damage from the formation of lipid peroxidation and reactive oxygen species. do.
  • the tissue 150 is chemically treated in an Equilibration Solution and a Vitrification Solution, which are media for vitrification.
  • ES Equilibration Solution
  • HEPES solution is formed by mixing HEPES solution, supplemented solution, ethylene glycol (Ethylene Glycol), dimethyl sulphoxide (DMSO), and SSS (or SPS) in a specific ratio.
  • ethylene glycol Ethylene Glycol
  • DMSO dimethyl sulphoxide
  • SSS SSS
  • Vitrification Solution is formed by mixing HEPES solution, sucrose, ethylene glycol (Ethylene Glycol), dimethyl sulphoxide (DMSO), and SSS (or SPS) in a specific ratio.
  • the tissue 150 is placed on the tissue seating unit 130 and treated with chemicals for 25 minutes in an Equilibration Solution (ES), which is one of the media for vitrification, and then the tissue 150 using sterile gauze. ) From the Equilibration Solution (ES). Thereafter, the tissue 150 is placed on the tissue seating unit 130 and is treated with chemicals for 15 minutes in a vitrification solution (VS). Thereafter, the vitrification solution is removed from the tissue 150 using sterile gauze.
  • ES Equilibration Solution
  • VS vitrification solution
  • the tissue seating unit 130 is inserted into the liquid nitrogen communication unit 160 and the tissue 150 is rapidly frozen and vitrified by the liquid nitrogen in the liquid nitrogen communication unit 160.
  • the chemically treated tissue 150 is inserted into the liquid nitrogen communication unit 160 as it is placed on the tissue seating unit 130, and is vitrified by the liquid nitrogen.
  • the vitrification process of the tissue 150 is a process in which the chemically treated tissue 150 is wound in liquid nitrogen of the liquid nitrogen communication unit 160 and rapidly cooled, so that the tissue 150 is changed into a vitreous tissue 150.
  • the tissue storage unit 110 is inserted into the liquid nitrogen communication unit 160. Then, liquid nitrogen is contained in the storage case 114. Inside the liquid nitrogen communication 160, the tissue mounting portion 130 is inserted into the storage case 114 and mounted. At this time, the tissue 150 is immersed in liquid nitrogen in the inner space of the storage case 114.
  • the present invention seals the tissue storage unit 110 without holding the storage case 114 containing liquid nitrogen by hand, so that the tissue seating unit 130, which has been pointed out as a problem in the prior art, is a storage case 114 in which liquid nitrogen is stored. ), which frequently occurs in the process of sealing, can prevent burns caused by contact with liquid nitrogen.
  • the inventors' tissue rapid freezing storage device 100 comes out of the liquid nitrogen communication unit 160, is mounted on a dipper, and stored frozen in a freezing storage tank 180.
  • the freezing storage tank 180 is a tank in which liquid nitrogen is stored, and the inner space is opened and closed by the tank lid.
  • the tissue 150 is stored in the liquid nitrogen stored in the tissue storage unit 110.
  • vitrification of the tissue 150 is maintained, and thermal deformation of the tissue 150 due to a temperature difference between liquid nitrogen and room temperature, which has been pointed out as a problem in the prior art, can be prevented.
  • the present invention prevents damage to the tissue 150 during the freezing process of the tissue 150, so that when a tissue 150 transplantation surgery is performed by defrosting the frozen tissue 150 later, the surgical performance can be improved. I can.
  • lid holder 113 operation member
  • tissue seating unit 160 liquid nitrogen communication
  • the present invention is applicable to the field of frozen storage of tissues such as ovaries.

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Thermal Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

A rapid-freezing storage device for tissue according to an embodiment of the present invention comprises: a tissue seating part which has a cylindrical shape with an open upper portion and on which tissue is placed; and a tissue storage part comprising a storage case which has a cylindrical shape with an open upper portion and on which the tissue seating part is mounted, a storage lid for sealing the internal space of the storage case, and a manipulation member for manipulating the movement of the storage lid to enable the storage lid to be fastened to the storage case while the storage lid moves up and down with respect to the storage case, wherein tissue is placed on the tissue seating part and vitrified by liquid nitrogen inside a liquid nitrogen barrel, and after the tissue seating part is inserted into the storage case containing liquid nitrogen inside the liquid nitrogen barrel, the vitrified tissue is frozen and stored in the tissue storage part to maintain the vitrification thereof by liquid nitrogen contained in the storage case as the storage lid is fastened to the storage case by manipulation of the manipulation member.

Description

조직의 급속동결 보관장치 및 조직의 급속동결 보관방법Rapid freezing storage device for tissues and storage method for rapid freezing tissues
본 발명은 조직의 급속동결 보관장치 및 조직의 급속동결 보관방법에 관한 것이며, 상세하게는 조직의 유리화 과정 및 유리화된 조직을 밀봉하는 과정이 액화질소통 내부에서 연속 진행되어, 유리화된 조직을 밀봉하는 과정에서 발생가능한 유리화된 조직의 온도와 상온 간의 온도차이에 의한 조직의 손상을 방지할 수 있는 조직의 급속동결 보관장치 및 조직의 급속동결 보관방법에 관한 것이다.The present invention relates to a rapid freezing storage device for tissues and a method for storing rapid freezing tissues, and in detail, the process of vitrifying tissue and sealing the vitrified tissue is continuously carried out inside the liquid nitrogen communication system to seal the vitrified tissue. The present invention relates to a rapid freezing storage device for tissues and a rapid freezing storage method for tissues capable of preventing damage to tissues due to a temperature difference between the temperature of the vitrified tissues and room temperature that may occur during the process.
생식세포는 모태 내에서 수정 후 태아의 난황 내에서 발생해 태아 내로 이동하며, 여자의 경우 성분화 과정을 통해 난소로 분화된다. 이 시기에 만들어진 난자는 제1감수분열기 전기에서 멈춘 상태로 난소 내에 유지된다.After fertilization in the mother's womb, reproductive cells develop in the egg yolk of the fetus and move into the fetus. In the case of women, they differentiate into ovaries through the process of componentization. The eggs created during this period are held in the ovary in a state of being stopped at the beginning of the first meiosis phase.
출생 후 체내의 난자 중 일부는 성숙 과정을 통해 원시난포(primordial follicle), 1차 난포(primary follicle), 2차 난포(secondary follicle) 및 3차 난포(tertiary follicle)를 거치는 일련의 과정을 통해 난소에서 난자가 배출되어 생식 세포로서의 역할을 하게 된다. After birth, some of the eggs in the body are matured through a series of processes that go through a primary follicle, a primary follicle, a secondary follicle, and a tertiary follicle. The egg is released from the body and plays a role as a reproductive cell.
임신 20주째 태아 난소내의 난자는 약 700만 개가 존재하나, 추가적인 난자의 생산이 없는 상태로 출생 후 난자의 개수는 200만 개로 감소하고, 지속적으로 그 숫자가 감소해 사춘기가 시작될 시기에는 약 50만 개로 감소 되며, 여성의 일생 동안 배출되는 난자의 개수는 일반적으로 300 내지 500개로 한정된다.At the 20th week of pregnancy, there are about 7 million eggs in the fetal ovary, but the number of eggs after birth decreases to 2 million, and the number continues to decrease to about 500,000 at the beginning of puberty. It is reduced to dogs, and the number of eggs released during a woman's lifetime is generally limited to 300 to 500.
여성암 환자에서 가임력을 보존하기 위한 동결 방법에는 배아동결, 난자동결, 난소조직동결 등이 있다. 이들 중 가장 적절한 방법의 선택은 항암치료 시기와 약제, 암의 종류, 환자의 연령과 배우자 유무에 따라 달라진다. Freezing methods for preserving fertility in female cancer patients include embryo freezing, egg automatic freezing, and ovarian tissue freezing. The selection of the most appropriate method among these depends on the timing and drug of chemotherapy, the type of cancer, the age of the patient and the presence of a spouse.
현재 임상적으로 확립된 방법은 배아와 난자의 동결보존이나, 이는 과배란 유도를 위해 치료를 미룰 수 없는 여성에서는 불가능한 방법이다. 반면, 난소의 동결보존은 사춘기 이전의 소아와 항암 치료를 미룰 수 없는 여성 등 모든 여성에서 가능한 방법이다. The currently clinically established method is cryopreservation of embryos and eggs, but this is an impossible method in women who cannot delay treatment to induce superovulation. On the other hand, cryopreservation of the ovaries is possible in all women, including children before puberty and women who cannot delay chemotherapy.
난소조직 동결의 주된 목표는 환자가 완치됐거나 질병의 치료가 끝났을 때 골반 내(orthotopic site) 혹은 상완, 복벽 등 골반 이외의 장소(heterotopic site)에 동결 보존된 난소 조직을 이식하는 것이다.The main goal of ovarian tissue freezing is to implant cryopreserved ovarian tissue in the orthotopic site or at a heterotopic site, such as the upper arm or abdominal wall, when the patient is healed or the disease has been treated.
난소조직의 동결 보존시 과립세포(granulosa cell)와 기질세포(stromal cell) 뿐 아니라 난자까지 동결보호제(cryoprotective agent; CPA)가 적절히 투과되는 것이 빙정(ice crystal) 형성을 예방하기 위해 필요하지만, 이와 함께 고농도의 동결보호제(CPA)가 가지고 있는 독성을 고려해야 한다. When cryopreservation of ovarian tissue, it is necessary to prevent the formation of ice crystals to adequately permeate the cryoprotective agent (CPA) to not only granulosa cells and stromal cells, but also eggs. Together, the toxicity of high concentrations of cryoprotectants (CPA) should be considered.
지금까지 인간난소 동결보존 시 프로판디올(propanediol, PROH), 디메틸술폭시드(dimethyl sulfoxide, DMSO) 또는 에틸렌글리콜(ethylene glycol)을 동결보호제(CPA)로 사용한 완만동결(slow-freezing)이 표준화된 방법으로 사용되고 있었다. 다만, 완만동결(slow-freezing)을 구현하는 장치는 수천만원 대의 고가의 장비가 사용되는 바 대형 전문 병원이 아니고서는 장비를 사용하기 어렵고, 조직 동결 시간이 오래 걸리는 단점이 있다. Until now, a standardized method of slow-freezing using propanediol (PROH), dimethyl sulfoxide (DMSO) or ethylene glycol as a cryoprotectant (CPA) for cryopreservation of human ovaries. Was being used. However, a device that implements slow-freezing uses expensive equipment of tens of thousands of won, so it is difficult to use the equipment except for a large specialized hospital, and it takes a long time to freeze the tissue.
최근 난소조직 동결 시 빙정에 의한 손상을 예방할 수 있는 급속동결법인 유리화(vitrification) 방법을 사용하여 좋은 결과를 보이는 연구들이 발표되고 있다. 유리화동결은 액화질소에 난소 조직을 담그면 -180℃로 급냉이 이루어지는 과정이다. Recently, studies showing good results using the vitrification method, a rapid freezing method that can prevent damage caused by ice crystals during freezing of ovarian tissue, have been published. Vitrification freezing is a process in which ovarian tissue is immersed in liquid nitrogen and rapidly cooled to -180°C.
유리화동결은 매우 짧은 시간 내에 조직을 액체 질소에 넣어야 하기 때문에 이 절차에 가장 적합한 도구가 필요하다. 난자 또는 배아를 동결하는 경우, Kitazato사의 CryotopTM, CooperSurgical사의 CryoleafTM 등의 도구가 사용되고 있다. Vitrification freezing requires tissues to be placed in liquid nitrogen within a very short period of time, so the most suitable tool for this procedure is required. In the case of freezing eggs or embryos, tools such as Kitazato's Cryotop TM and CooperSurgical's Cryoleaf TM are used.
도 1을 참조하여, 유리화동결에 사용되는 제품 중 하나인 Kitazato 제품을 이용하여, 난소조직을 동결시키는 과정에 대해 설명하면 다음과 같다. Referring to FIG. 1, a process of freezing ovarian tissue using a Kitazato product, which is one of the products used for vitrification, will be described as follows.
우선, 도 1(a)에 도시된 바와 같이, 동결보존하기 위한 조직이 준비된다. 다음으로, 도 1(b)에 도시된 바와 같이, 조직이 유리화용 메디아(vitrification media)에 담긴다. 이러한 유리화용 메디아 처리는, 조직에서 수분이 빠져나가는 것을 방지하기 위한 것이다. First, as shown in Fig. 1 (a), a tissue for cryopreservation is prepared. Next, as shown in Fig. 1 (b), the tissue is contained in a vitrification media. This vitrification media treatment is for preventing moisture from escaping from the tissue.
도 1(c)에 도시된 바와 같이, 유리화용 메디아 처리된 조직은 키트에 놓인다. 그리고, 키트에 놓인 조직이 액화질소통에 삽입되어, 액화질소에 의해 유리화되는 과정이 진행된다. 조직이 유리화되면, 키트는 -180℃의 액화질소통에서 나와 상온에서, 도 1(d)에 도시된 바와 같이 키트가 액화질소가 담긴 케이스에 밀봉된다. As shown in Figure 1 (c), the media-treated tissue for vitrification is placed in a kit. Then, the tissue placed in the kit is inserted into the liquid nitrogen communication system, and the process of vitrification by the liquid nitrogen proceeds. When the tissue is vitrified, the kit comes out of the liquid nitrogen cylinder at -180°C and at room temperature, the kit is sealed in a case containing liquid nitrogen as shown in FIG. 1(d).
다만 도 1(a) 내지 도 1(d)에 도시된 과정이 진행되면서, 다음과 같은 문제점이 발생될 가능성이 있다. However, as the process shown in FIGS. 1(a) to 1(d) proceeds, the following problems may occur.
키트가 액화질소통에서 나오는 과정에서, 액화질소(-180℃)와 상온 사이의 급격한 온도변화로 인해, 조직이 변형될 가능성이 발생한다. 난소조직 동결의 주된 목표는 환자가 완치됐거나 질병의 치료가 끝났을 때 골반 내(orthotopic site) 혹은 상완, 복벽 등 골반 이외의 장소(heterotopic site)에 동결 보존된 난소 조직을 이식하기 위한 것인데, 변형된 난소 조직은 이식에 사용될 수 없는 문제가 있다. In the process of the kit coming out of the liquid nitrogen communication, there is a possibility that the tissue may be deformed due to the rapid temperature change between the liquid nitrogen (-180°C) and room temperature. The main goal of ovarian tissue freezing is to transplant cryopreserved ovarian tissue into the pelvis (orthotopic site) or at a heterotopic site such as the upper arm or abdominal wall when the patient is cured or the disease is over. Ovarian tissue has a problem that cannot be used for transplantation.
또한, 액화질소가 담긴 케이스의 온도가 -180℃로 매우 낮기 때문에, 키트가 케이스에 밀봉되는 과정에서 액화질소가 케이스의 외부로 흘러나오면 케이스를 잡고 있는 작업자의 손에 화상과 같은 사고가 발생될 가능성이 존재한다. In addition, since the temperature of the case containing liquid nitrogen is very low at -180℃, if liquid nitrogen flows out of the case while the kit is sealed to the case, an accident such as a burn may occur on the hand of the operator holding the case. The possibility exists.
[선행기술문헌][Prior technical literature]
(특허문헌 1) 일본등록특허 제5825571호에는 생체 시료를 동결 보존 하기 위한 동결 보존 용구가 개시되어 있다. (Patent Document 1) Japanese Patent No. 5825571 discloses a cryopreservation tool for cryopreserving a biological sample.
본 발명은 조직의 유리화 과정 및 유리화된 조직을 밀봉하는 과정이 액화질소통 내부에서 연속 진행되어, 유리화된 조직을 밀봉하는 과정에서 발생가능한 유리화된 조직의 온도와 상온 간의 온도차이에 의한 조직의 손상을 방지할 수 있는 조직의 급속동결 보관장치 및 조직의 급속동결 보관방법을 제공하는 것을 목적으로 한다.In the present invention, the process of vitrifying the tissue and the process of sealing the vitrified tissue are continuously carried out inside the liquid nitrogen communication, and damage to the tissue due to the temperature difference between the temperature of the vitrified tissue and room temperature that can occur in the process of sealing the vitrified tissue The purpose of this study is to provide a quick-freezing storage device for tissues and a rapid-freezing storage method for tissues.
본 발명의 일 실시예에 따른 조직의 급속동결 보관장치는, 상부가 개방된 통형상을 가지며, 조직이 놓이는 조직안착부; 및 상부가 개방된 통형상을 가지며 조직안착부가 거치되는 보관케이스와, 보관케이스의 내부공간을 밀봉하는 보관뚜껑과, 보관뚜껑이 보관케이스에 대해 상하방향으로 이동되면서 보관뚜껑이 보관케이스에 결합되게 보관뚜껑의 이동을 조작하는 조작부재를 포함하는 조직보관부를 포함하되, 조직은 조직안착부에 놓여 액화질소통의 내부에서 액화질소에 의해 유리화되고, 유리화된 조직은 액화질소통 내부에서 조직안착부가 액화질소가 담긴 보관케이스로 삽입된 후, 조작부재의 조작에 의해 보관뚜껑이 보관케이스에 결합됨에 따라, 보관케이스에 담겨진 액화질소에 의해 유리화가 지속되게 조직보관부에 동결보관되는 것이 바람직하다. A tissue fast-freezing storage device according to an embodiment of the present invention has a cylindrical shape with an open top, and a tissue seating portion on which the tissue is placed; And a storage case with an open top and a tissue seat, a storage lid that seals the internal space of the storage case, and the storage lid is moved up and down with respect to the storage case so that the storage lid is coupled to the storage case. It includes a tissue storage unit including an operation member for manipulating the movement of the storage lid, wherein the tissue is placed on the tissue seating unit and is vitrified by liquid nitrogen in the liquid nitrogen communication unit, and the vitrified tissue is the tissue seating unit in the liquid nitrogen communication unit. After being inserted into the storage case containing liquid nitrogen, it is preferable to be frozen and stored in the tissue storage unit so that vitrification is continued by the liquid nitrogen contained in the storage case as the storage lid is coupled to the storage case by operation of the operating member.
본 발명의 일 실시예에 있어서, 조직보관부는, 상부가 개방된 통형상을 가지며 조직안착부가 거치되는 보관케이스와, 보관케이스의 내부공간을 밀봉하는 보관뚜껑과, 보관케이스와 보관뚜껑에 연결되어 보관뚜껑이 보관케이스에 결합되어 내부공간을 밀봉하도록 작동되는 조작부재를 포함하고, 조직보관부는 액화질소통의 내부에서, 조직이 내부공간에서 액화질소에 잠기게 조직안착부가 보관케이스에 거치되면, 조작부재에 의해 보관뚜껑이 보관케이스에 결합되게 작동되어, 조직안착부가 보관케이스의 내부공간에 밀봉되도록 하는 것이 바람직하다.In one embodiment of the present invention, the tissue storage unit is connected to the storage case and the storage lid sealing the inner space of the storage case and the storage case and the storage lid, the storage case having an open top and a tissue seat The storage lid is coupled to the storage case and includes an operation member operated to seal the internal space, and the tissue storage unit is mounted in the storage case so that the tissue is immersed in the liquid nitrogen in the liquid nitrogen communication unit, It is preferable that the storage lid is operated to be coupled to the storage case by the operation member, so that the tissue seating portion is sealed in the inner space of the storage case.
본 발명의 일 실시예에 있어서, 조직보관부는, 보관케이스가 거치되는 케이스거치부와, 케이스거치부의 상부에서 케이스거치부와 마주보게 위치되고 보관뚜껑이 거치되는 뚜껑거치부를 더 포함하고, 조작부재는 뚜껑거치부와 케이스거치부를 연결하여 케이스거치부와 뚜껑거치부 간의 간격을 조작하는 것이 바람직하다. In an embodiment of the present invention, the tissue storage unit further includes a case holder on which the storage case is mounted, and a lid holder on which the case holder is placed facing the case holder and on which the storage lid is mounted, and an operation member It is preferable to connect the lid holder and the case holder to manipulate the gap between the case holder and the lid holder.
본 발명의 일 실시예에 있어서, 조직안착부는 바닥면이 메쉬망으로 이루어져, 조직이 유리화되기 전, 유리화용 메디아에 의해 약품처리될 때, 조직안착부가 조직이 안착된 상태로, 유리화용 메디아가 담긴 약품용기로 삽입되어 유리화용 메디아에 담겨져 약품처리되는 것이 바람직하다.In one embodiment of the present invention, the tissue seating portion is made of a mesh net, and before the tissue is vitrified, when chemically treated by the vitrification media, the tissue mounting portion is in a state in which the tissue is seated, and the vitrification media is It is preferable that it is inserted into the contained medicine container and contained in the vitrification media for chemical treatment.
본 발명의 일 실시예에 있어서, 조직안착부는 바닥면이 열전도율이 높은 재질로 이루어진 것이 바람직하다. In one embodiment of the present invention, it is preferable that the bottom surface of the tissue seating portion is made of a material having high thermal conductivity.
한편, 본 발명의 일 실시예에 따른 조직의 급속동결 보관방법은, (A) 조직이 조직안착부에 놓인 상태로, 유리화용 메디아에 의해 약품처리되는 단계; (B) 조직안착부가 액화질소통의 내부로 삽입되어 액화질소통 내의 액화질소에 의해 조직이 급속동결되어 유리화되는 단계; (C) 보관케이스, 보관뚜껑 및 조작부재를 포함하는 조직보관부가 액화질소통의 내부로 삽입되고, 보관케이스에 액화질소가 담기는 단계; (D) 조직안착부가 보관케이스로 삽입되어 거치되어, 조직이 보관케이스의 내부공간에서 액화질소에 잠기는 단계; (E) 조작부재에 의해 보관뚜껑이 보관케이스에 결합되게 작동되어, 조직이 내부공간의 액화질소에 담겨진 상태로 밀봉하는 단계; 및 (F) 조직보관부가 보관케이스 내의 액화질소에 의해 냉기가 유지된 상태로, 액화질소통 밖으로 나와 동결보관탱크로 삽입되어, 동결보관탱크에서 조직보관되는 단계를 포함하는 것이 바람직하다. On the other hand, the method for storing the tissue for rapid freezing according to an embodiment of the present invention comprises the steps of: (A) the tissue is placed on the tissue seating unit, and is treated with a drug by a vitrification media; (B) a step in which the tissue seating portion is inserted into the liquid nitrogen communication and the tissue is rapidly frozen and vitrified by the liquid nitrogen in the liquid nitrogen communication; (C) the tissue storage unit including the storage case, the storage lid and the operation member is inserted into the interior of the liquid nitrogen communication, and the liquid nitrogen is contained in the storage case; (D) the tissue seating portion is inserted into the storage case and mounted, so that the tissue is immersed in liquid nitrogen in the inner space of the storage case; (E) the storage lid is operated to be coupled to the storage case by the operation member, and sealing the tissue in a state immersed in liquid nitrogen in the internal space; And (F) the tissue storage unit in a state in which cold air is maintained by the liquid nitrogen in the storage case, comes out of the liquid nitrogen communication and is inserted into the freezing storage tank, and the tissue storage in the freezing storage tank is preferably included.
본 발명의 일 실시예에 있어서, B 단계 내지 E단계는 액화질소통에서 순차적으로 진행되는 것이 바람직하다. In one embodiment of the present invention, it is preferable that steps B to E are sequentially performed in liquid nitrogen communication.
본 발명의 일 실시예에 있어서, F단계에서, 조직보관부는 동결보관탱크에 거치되는 디퍼에 안착되어, 동결보관탱크 내의 액화질소에 잠기게 위치되는 것이 바람직하다.In an embodiment of the present invention, in step F, it is preferable that the tissue storage unit is seated in a dipper mounted on a freezing storage tank and positioned so as to be immersed in liquid nitrogen in the freezing storage tank.
본 발명은 조직의 유리화 과정 및 유리화된 조직을 밀봉하는 과정이 액화질소통 내부에서 연속 진행되어, 기존에 유리화된 조직이 상온에서 액화질소가 담긴 용기에 밀봉되는 과정에서 발생가능한, 유리화된 조직의 온도와 조직이 밀봉되는 상온에서의 온도 차이에 의한 조직의 손상을 방지할 수 있다. In the present invention, the vitrification process of the tissue and the process of sealing the vitrified tissue are continuously performed inside the liquid nitrogen communication system, and the vitrified tissue, which can occur during the process of sealing the existing vitrified tissue in a container containing liquid nitrogen at room temperature. It is possible to prevent damage to the tissue caused by the temperature difference between the temperature and the temperature at which the tissue is sealed.
본 발명은 조직의 동결 및 밀봉과정에서 조직의 손상을 방지하여, 항암치료 후, 해동된 조직을 이용한 조직의 이식수술의 성공율을 증대시킬 수 있다. The present invention prevents tissue damage during the process of freezing and sealing the tissue, and after chemotherapy, it is possible to increase the success rate of tissue transplantation using the thawed tissue.
아울러, 본 발명은 조직이 조직안착부에 놓인 상태로 유리화용 메디아에 의해 약품처리되어, 종래기술과 비교하여 유리화용 메디아에 의해 약품처리된 조직을 조직의 유리화에 사용되는 키트로 옮기는 과정을 생략하여, 조직의 동결 전 전처리 과정의 작업효율을 향상시킬 수 있다. In addition, the present invention eliminates the process of transferring the drug-treated tissue by the vitrification media to the kit used for vitrification of the tissue compared to the prior art by being chemically treated by the vitrification media while the tissue is placed on the tissue seat. Thus, it is possible to improve the work efficiency of the pretreatment process before freezing the tissue.
또한, 본 발명은 조작부재의 간단한 조작만으로도 보관케이스에 보관뚜껑이 결합되어 조직이 액화질소가 담긴 보관케이스에 밀봉되게 하여, 작업자가 액화질소가 담긴 부분인 보관케이스와 접촉하지 않고도 유리화된 조직을 조직보관부에 밀봉하게 할 수 있다. In addition, the present invention allows the storage lid to be coupled to the storage case with only a simple operation of the operating member, so that the tissue is sealed in the storage case containing liquid nitrogen, so that the operator can remove the vitrified tissue without contacting the storage case, which is a part containing liquid nitrogen. It can be sealed in the tissue storage area.
이로 인해, 종래기술의 문제점으로 거론됐던 유리화된 조직이 놓인 키트가 액화질소가 담긴 케이스에 밀봉되는 과정에서, 즉, 작업자가 액화질소가 담긴 케이스를 잡은 상태로 키트에 연결된 뚜껑을 케이스에 결합하는 과정에서, 케이스의 외부로 액화질소가 흘러나오면서 케이스를 잡고 있는 작업자의 손에 액화질소가 접촉되어, 액화질소에 의해 작업자가 화상을 입는 사고를 방지할 수 있다. Due to this, in the process of sealing the kit with the vitrified tissue, which was discussed as a problem in the prior art, in a case containing liquid nitrogen, that is, in a state in which the operator holds the case containing liquid nitrogen, the lid connected to the kit is coupled to the case. In the process, as liquid nitrogen flows out of the case, the liquid nitrogen comes into contact with the hand of a worker holding the case, thereby preventing an accident in which the worker is burned by the liquid nitrogen.
도 1은 종래기술에 따른 조직 동결 방법을 설명하기 위한 도면이다. 1 is a view for explaining a tissue freezing method according to the prior art.
도 2는 본 발명의 일 실시예에 따른 조직의 급속동결 보관장치의 구성도를 개략적으로 도시한 것이다. Figure 2 is a schematic diagram showing the configuration of a tissue storage device for rapid freezing according to an embodiment of the present invention.
도 3 및 도 4는 조직안착부가 조직보관부에 밀봉되는 과정을 설명하기 위한 도면이다. 3 and 4 are views for explaining a process in which the tissue seating unit is sealed to the tissue storage unit.
도 5는 다른 예에 따른 조직보관부를 설명하기 위한 도면이다. 5 is a view for explaining a tissue storage unit according to another example.
도 6은 본 발명인 조직의 급속동결 보관장치가 동결보관탱크에 삽입되어, 동결보관되는 과정을 설명하기 위한 도면이다. Figure 6 is a view for explaining the process of the inventors of the rapid freezing storage device of the tissue is inserted into a freezing storage tank, frozen storage.
본 발명의 일 실시예에 따른 조직의 급속동결 보관장치는, 상부가 개방된 통형상을 가지며, 조직이 놓이는 조직안착부; 및 상부가 개방된 통형상을 가지며 조직안착부가 거치되는 보관케이스와, 보관케이스의 내부공간을 밀봉하는 보관뚜껑과, 보관뚜껑이 보관케이스에 대해 상하방향으로 이동되면서 보관뚜껑이 보관케이스에 결합되게 보관뚜껑의 이동을 조작하는 조작부재를 포함하는 조직보관부를 포함하되, 조직은 조직안착부에 놓여 액화질소통의 내부에서 액화질소에 의해 유리화되고, 유리화된 조직은 액화질소통 내부에서 조직안착부가 액화질소가 담긴 보관케이스로 삽입된 후, 조작부재의 조작에 의해 보관뚜껑이 보관케이스에 결합됨에 따라, 보관케이스에 담겨진 액화질소에 의해 유리화가 지속되게 조직보관부에 동결보관되는 것이 바람직하다. A tissue fast-freezing storage device according to an embodiment of the present invention has a cylindrical shape with an open top, and a tissue seating portion on which the tissue is placed; And a storage case with an open top and a tissue seat, a storage lid that seals the internal space of the storage case, and the storage lid is moved up and down with respect to the storage case so that the storage lid is coupled to the storage case. It includes a tissue storage unit including an operation member for manipulating the movement of the storage lid, wherein the tissue is placed on the tissue seating unit and is vitrified by liquid nitrogen in the liquid nitrogen communication unit, and the vitrified tissue is the tissue seating unit in the liquid nitrogen communication unit. After being inserted into the storage case containing liquid nitrogen, it is preferable to be frozen and stored in the tissue storage unit so that vitrification is continued by the liquid nitrogen contained in the storage case as the storage lid is coupled to the storage case by operation of the operating member.
이하에서는 첨부도면을 참조하여, 본 발명의 바람직한 실시예에 따른 조직의 급속동결 보관장치 및 조직의 급속동결 보관방법에 대해 설명하기로 한다. Hereinafter, with reference to the accompanying drawings, a description will be given of a quick-freezing storage apparatus for tissues and a rapid-freezing storage method for tissues according to a preferred embodiment of the present invention.
본 발명의 일 실시예에 따른 조직의 급속동결 보관장치는 급속냉각되어 유리화된 조직을 조직보관하기 위한 것이다. 조직은 항암치료 전 인체에서 획득된 것으로, 항암치료 후 인체에 다시 이식하기 위한 것이다. 인체에 이식된 조직이 원하는 효과를 이루기 위해서는, 조직보관과정에서 조직의 변형이 발생되지 않아야 한다.A tissue storage device for rapid freezing of a tissue according to an embodiment of the present invention is for storing tissue that is rapidly cooled and vitrified. The tissue was obtained from the human body before chemotherapy, and is intended to be transplanted back into the human body after chemotherapy. In order for the tissue transplanted into the human body to achieve the desired effect, the tissue must not be deformed during the tissue storage process.
본 발명은 조직의 유리화 및 조직이 조직보관부에 밀봉되는 과정이 액화질소통 내부에서 연속 진행되어, 유리화된 조직을 액화질소와 함께 조직보관부에 밀봉한다. 이후, 조직이 밀봉된 조직보관부는 액화질소통에서 나온 후, 동결보관탱크에 보관된다. 동결보관탱크는 액화질소가 담긴 탱크이다. In the present invention, the process of vitrifying the tissue and sealing the tissue to the tissue storage unit proceeds continuously within the liquid nitrogen communication unit, thereby sealing the vitrified tissue to the tissue storage unit together with liquid nitrogen. Thereafter, the tissue storage unit in which the tissue is sealed comes out of the liquid nitrogen communication and is then stored in a freezing storage tank. The freezing storage tank is a tank containing liquid nitrogen.
도 2에 도시된 바와 같이, 조직의 급속동결 보관장치(100)는 조직보관부(110) 및 조직안착부(130)를 포함한다. As shown in Figure 2, the tissue storage device for rapid freezing 100 includes a tissue storage unit 110 and a tissue seating unit 130.
조직안착부(130)는 상부가 개방된 통형상을 가진다. 조직안착부(130)는 바닥면에 조직(150)이 놓인다. 조직안착부(130)는 바닥면이 메쉬망으로 이루어져, 조직(150)이 조직안착부(130)에 놓인 상태로 유리화용 메디아에 의해 약품처리되게 할 수 있다. The tissue seating portion 130 has a cylindrical shape with an open top. The tissue seating unit 130 is placed on the tissue 150 on the bottom surface. The tissue seating unit 130 may have a bottom surface made of a mesh network, so that the tissue 150 is placed on the tissue seating unit 130 to be treated with chemicals by the vitrification media.
조직(150)은 조직안착부(130)에 안착된 상태로, 액화질소에 의해 급속냉각되면서 유리화된다. 조직안착부(130)의 바닥면은 열전도율이 높은 재질로 이루어져, 액화질소에 의한 조직의 급속냉각효율을 높일 수 있다. 열전도율이 높은 재질로는 은, 구리, 알루미늄, 스테인리스강, 질화알루미늄, 질화규소, 알루미나, 금속 분말, 질화 알루미늄 등 중 어느 하나가 선택될 수 있다. The tissue 150 is vitrified while being rapidly cooled by liquid nitrogen in a state seated on the tissue mounting portion 130. The bottom surface of the tissue seating unit 130 is made of a material having a high thermal conductivity, so that the rapid cooling efficiency of the tissue by liquid nitrogen may be increased. As the material having high thermal conductivity, any one of silver, copper, aluminum, stainless steel, aluminum nitride, silicon nitride, alumina, metal powder, aluminum nitride, and the like may be selected.
조직안착부(130)의 상단에는 손잡이(131)가 마련된다. 이는, 조직(150)의 유리화 과정에서, 조직(150)의 유리화 과정에서, 작업자가 조직안착부(130)를 안정적으로 잡은 상태에서, 조직안착부(130)를 액화질소에 담근 상태로 살살 흔들면서 조직(150)의 유리화를 보다 원활하게 도모하게 할 수 있다. 이와 더불어, 작업자가 액화질소에 접촉되는 것을 방지하여, 조직(150)의 유리화 과정에서 액화질소에 의한 작업자의 부상을 방지할 수 있다. 손잡이(131)는 조직안착부(130)가 조직보관부에 밀봉되는 과정에서, 조직안착부(130)에서 제거가능하다. A handle 131 is provided on the upper end of the tissue seating part 130. This is, in the process of vitrifying the tissue 150, in the process of vitrifying the tissue 150, while the operator stably holds the tissue seat 130, gently shake the tissue seat 130 in a state immersed in liquid nitrogen. While it is possible to promote the vitrification of the tissue 150 more smoothly. In addition, by preventing the operator from contacting the liquid nitrogen, it is possible to prevent the operator from being injured by the liquid nitrogen during the vitrification process of the tissue 150. The handle 131 can be removed from the tissue mounting portion 130 in the process of sealing the tissue mounting portion 130 to the tissue storage portion.
조직(150)의 유리화 후, 조직안착부(130)는 조직보관부(110)의 보관케이스(114)로 삽입된다. 조직안착부(130)는 상단이 보관케이스(114)의 상단에 걸리고, 조직안착부(130)의 바닥면이 보관케이스(114)의 바닥면과 이격되게, 보관케이스(114)에 거치된다. 이때, 보관케이스(114)의 내부에는 액화질소가 담긴 상태이다. 조직안착부(130)는 조작부재(113)의 조작에 의해 보관케이스(114) 및 보관뚜껑(115)이 상호 간에 조립되면서 조직보관부(110)의 내부공간에 밀봉된다. After vitrification of the tissue 150, the tissue seating unit 130 is inserted into the storage case 114 of the tissue storage unit 110. The tissue seating portion 130 is mounted on the storage case 114 so that the upper end of the tissue seating portion 130 is caught on the upper end of the storage case 114 and the bottom surface of the tissue seating portion 130 is spaced apart from the bottom surface of the storage case 114. At this time, liquid nitrogen is contained in the storage case 114. The tissue seating unit 130 is sealed in the inner space of the tissue storage unit 110 while the storage case 114 and the storage lid 115 are assembled with each other by the manipulation of the operation member 113.
조직보관부(110)는 케이스거치부(111), 뚜껑거치부(112), 보관케이스(114), 보관뚜껑(115) 및 조작부재(113)로 이루어진다. 조직보관부(110)는 유리화된 조직(150)을 동결보관하기 위한 용기이다. 유리화된 조직(150)은 조직안착부(130)에 놓인 상태로, 조직보관부(110)에 밀봉되어 보관된다. 이때, 유리화된 조직(150)은 보관케이스(114)에 저장된 액화질소에 담겨진 상태로 조직보관부(110)에 보관된다. The tissue storage unit 110 is composed of a case holder 111, a lid holder 112, a storage case 114, a storage lid 115, and an operation member 113. The tissue storage unit 110 is a container for freezing the vitrified tissue 150. The vitrified tissue 150 is sealed and stored in the tissue storage unit 110 in a state placed on the tissue seating unit 130. At this time, the vitrified tissue 150 is stored in the tissue storage unit 110 in a state immersed in liquid nitrogen stored in the storage case 114.
보관케이스(114)는 상부가 개방된 통형상을 가진다. 보관케이스(114)는 조직안착부(130)가 거치되는 용기이다. 보관케이스(114)는 조직안착부(130)가 내부공간으로 삽입되어 거치가능한 크기로 제작된다. 보관케이스(114)는 보관뚜껑(115)과의 결합시, 내부공간이 밀봉된다. The storage case 114 has a cylindrical shape with an open top. The storage case 114 is a container in which the tissue seating unit 130 is mounted. The storage case 114 is manufactured in a size in which the tissue seating portion 130 is inserted into the inner space and can be mounted. When the storage case 114 is combined with the storage lid 115, the inner space is sealed.
보관케이스(114)에는 액화질소가 담긴다. 보관케이스(114)에는 복수의 개구(114a)가 마련된다 복수의 개구(114a)는, 보관케이스(114)의 내부공간에서 기화된 액화질소가 보관케이스(114)의 외부로 빠져나가는 통로이다. 기화된 액화질소가 복수의 개구(114a)를 통해 보관케이스(114)의 밖으로 이동됨에 따라, 보관케이스(114)가 보관뚜껑(115)에 의해 밀봉된 후, 액화질소가 기화되면서 보관케이스(114)의 내부공간의 압력이 높아져, 보관뚜껑(115)이 보관케이스(114)에서 분리되는 것을 방지할 수 있다. The storage case 114 contains liquid nitrogen. The storage case 114 is provided with a plurality of openings 114a. The plurality of openings 114a are passages through which liquid nitrogen vaporized in the internal space of the storage case 114 exits to the outside of the storage case 114. As the vaporized liquid nitrogen is moved out of the storage case 114 through the plurality of openings 114a, the storage case 114 is sealed by the storage lid 115, and then the liquid nitrogen is vaporized and the storage case 114 ), the pressure in the inner space of the inner space is increased, so that the storage lid 115 can be prevented from being separated from the storage case 114.
도 2 내지 도 4에 도시된 바와 같이, 보관케이스(114)는 케이스거치부(111)에 탈착가능하게 설치된다. 그리고, 보관뚜껑(115)은 뚜껑거치부(112)에 탈착가능하게 설치된다. 케이스거치부(111) 및 뚜껑거치부(112)는 조작부재(113)에 의해 상호 간에 연결된다. 다른 한편, 도 5에 도시된 바와 같이, 본 발명(100a)은 조직보관부(110a)가 케이스거치부(111) 및/또는 뚜껑거치부(112) 없이, 보관케이스(114) 및 보관뚜껑(115)이 직접적으로 조작부재(113)에 설치될 수도 있다. 2 to 4, the storage case 114 is detachably installed on the case holder 111. And, the storage lid 115 is detachably installed on the lid holder 112. The case holder 111 and the lid holder 112 are connected to each other by an operation member 113. On the other hand, as shown in Figure 5, the present invention (100a) is a tissue storage unit (110a) without a case holder 111 and/or a lid holder 112, the storage case 114 and the storage lid ( 115) may be directly installed on the operation member 113.
조작부재(113)는 제1조작부재(113a)와 제2조작부재(113b)로 구성된다. 제1조작부재(113a)는 케이스거치부(111)의 측면에서, 상부로 돌출되게 설치된다. 제1조작부재(113a)의 상단에는 제1손잡이(113a1)가 마련된다. 그리고, 제1조작부재(113a)의 상단에는 디퍼걸이부(113a2)가 마련된다. 디퍼걸이부(113a2)는 조직보관부(110)가 디퍼(170)에 걸리게 마련된 고리이다. The operating member 113 is composed of a first operating member (113a) and a second operating member (113b). The first operation member 113a is installed to protrude upward from the side of the case holder 111. A first handle 113a1 is provided on an upper end of the first manipulation member 113a. In addition, a dipper hanger 113a2 is provided on the upper end of the first manipulation member 113a. The dipper hook portion 113a2 is a ring provided so that the tissue storage portion 110 is caught on the dipper 170.
작업자는 국자가 국솥에서 국을 푸듯이, 조작부재(113)의 상단에 마련된 제1손잡이(113a1) 및/또는 제2손잡이(113b1)를 잡고, 보관케이스(114) 부분만 액화질소통(160)의 액화질소로 담궈, 액화질소를 보관케이스(114)에 담는다. The operator holds the first handle (113a1) and / or the second handle (113b1) provided on the top of the operation member 113, as if a ladle scoops the soup in a soup pot, and only the portion of the storage case 114 is liquefied nitrogen communication 160 ), and put the liquid nitrogen in the storage case 114.
제2조작부재(113b)에는 보관뚜껑(115)이 연결된다. 이때, 보관뚜껑(115)은 보관케이스(114)의 상부에 위치된다. 제2조작부재(113b)의 상단에는 제2손잡이(113b1)가 마련된다. The storage lid 115 is connected to the second operation member 113b. At this time, the storage lid 115 is located above the storage case 114. A second handle 113b1 is provided on the upper end of the second manipulation member 113b.
제2조작부재(113b)는 제1조작부재(113a)에 대해 상하 이동가능하게, 제1조작부재(113a)에 결합된다. 제1조작부재(113a)에는 가이드홈(113a3)이 마련되고, 제2조작부재(113b)에는 가이드홈(113a3)을 따라 상하로 이동가능한 걸림돌기(113b2)가 마련된다. The second manipulation member 113b is coupled to the first manipulation member 113a so as to be movable up and down with respect to the first manipulation member 113a. The first manipulating member 113a is provided with a guide groove 113a3, and the second manipulating member 113b is provided with a locking protrusion 113b2 that can move up and down along the guide groove 113a3.
작업자는 제2손잡이(113b1)를 보관케이스(114)를 향해 누르는 동작을 통해 제2조작부재(113b)가 제1조작부재(113a)에 대해 하부로 이동되게 하여, 보관뚜껑(115)이 보관케이스(114)에 결합되게 조작할 수 있다. 또한, 작업자는 제2손잡이(113b1)를 상부로 잡아당겨, 제2조작부재(113b)가 제1조작부재(113a)에 대해 상부로 이동되게 하여, 보관뚜껑(115)이 보관케이스(114)에 분리되게 조작할 수 있다. The operator presses the second handle 113b1 toward the storage case 114 so that the second operation member 113b moves downward relative to the first operation member 113a, so that the storage lid 115 is stored. It can be manipulated to be coupled to the case 114. In addition, the operator pulls the second handle (113b1) upward, so that the second operation member (113b) is moved upward relative to the first operation member (113a), so that the storage lid (115) is the storage case (114) Can be operated separately.
본 실시예에 따른 액화질소가 담긴 보관케이스(114)를 손으로 잡지 않고도, 제2손잡이(113b1)를 아래로 누르거나 위로 잡아당기는 간단한 방식으로, 보관뚜껑(115)을 조직보관케이스(114)에 결합하거나 분리할 수 있다. 이에, 본 발명은 조직안착부(130)를 액화질소가 저장된 보관케이스(114)에 밀봉하는 과정에서 발생되는, 액화질소와의 접촉에 의한 화상을 방지할 수 있다. In a simple manner of pressing down or pulling the second handle 113b1 down, without holding the storage case 114 containing liquid nitrogen according to the present embodiment, the tissue storage case 114 Can be combined or separated. Accordingly, the present invention can prevent an image caused by contact with liquid nitrogen, which is generated in the process of sealing the tissue seating unit 130 to the storage case 114 in which liquid nitrogen is stored.
이하에서, 조직의 급속동결 보관방법에 대해 설명하면 다음과 같다.Hereinafter, a description will be given of a method of storing tissues for rapid freezing as follows.
우선, 조직(150)이 조직안착부(130)에 놓인 상태로, 유리화용 메디아에 의해 약품처리된다. 조직안착부(130)는 바닥면이 메쉬망으로 이루어져, 조직(150)이 조직안착부(130)에 놓인 상태로 유리화용 메디아에 의해 약품처리되게 할 수 있다. First, in a state in which the tissue 150 is placed on the tissue seating unit 130, chemical treatment is performed by the vitrification media. The tissue seating unit 130 may have a bottom surface made of a mesh network, so that the tissue 150 is placed on the tissue seating unit 130 to be treated with chemicals by the vitrification media.
종래기술과 비교하여, 본 발명은 유리화용 메디아에 의해 약품처리된 조직(150)을 키트로 옮기는 과정을 생략하여, 조직(150)의 동결 전 전처리 과정의 작업효율을 향상시킬 수 있다. Compared with the prior art, the present invention can improve the work efficiency of the pretreatment process prior to freezing of the tissue 150 by omitting the process of transferring the tissue 150 treated by the vitrification media to the kit.
조직(150)에 약품처리를 하는 이유는 투과성 동결 방지제는 용액의 유리 전이 온도를 낮추기 때문에 용액의 실제 동결을 방지하고, 세포 내 얼음 형성으로 인한 치명적인 스트레스를 유도 할 수 있기 때문이다. 동결 방지 용액에 완충제(buffers), 탄수화물(carbohydrates) (예컨대, 글루코오스(glucose), 젖당(lactose), 라피노스(raffinose), 수크로스(sucrose) 및 트레할로오스(trehalose)), 염(구연산나트륨(sodium citrate), 시트릭애씨드(citric acid)), 노른자위(egg yolk) 및 항생제 투과성 동결보호제 글리세롤(antibiotics permeable cryoprotectant glycerol) 등이 들어간다. 동결 방지제로 삼투압 평형을 이루어 혈장막(plasmatic membrane)과 미토콘트리아막(mitochondrial membrane)의 손상을 보호하고, 과산화지방질(lipid peroxidation) 및 활성산호(reactive oxygen species)의 형성에 대한 DNA 손상을 방지한다. The reason why the tissue 150 is treated with chemicals is that the permeable cryoprotectant lowers the glass transition temperature of the solution, thus preventing the solution from being actually frozen, and inducing a fatal stress due to ice formation in the cells. In antifreeze solutions, buffers, carbohydrates (e.g., glucose, lactose, raffinose, sucrose and trehalose), salts (sodium citrate) (sodium citrate), citric acid), egg yolk and antibiotics permeable cryoprotectant glycerol. As a cryoprotectant, the osmotic pressure is balanced to protect the plasma membrane and the mitochondrial membrane from damage, and to prevent DNA damage from the formation of lipid peroxidation and reactive oxygen species. do.
실온에서, 조직(150)은 유리화용 메디아인 균형용액(Equilibration Solution) 및 유리화 용액(Vitrification Solution)에서 약품처리된다. At room temperature, the tissue 150 is chemically treated in an Equilibration Solution and a Vitrification Solution, which are media for vitrification.
균형용액(Equilibration Solution, ES)은 HEPES 용액, 보충액(supplemented), 에틸렌글리콜(Ethylene Glycol), DMSO(dimethyl sulphoxide), SSS(또는 SPS)이 특정 비율로 혼합되어 형성된다. Equilibration Solution (ES) is formed by mixing HEPES solution, supplemented solution, ethylene glycol (Ethylene Glycol), dimethyl sulphoxide (DMSO), and SSS (or SPS) in a specific ratio.
유리화 용액(Vitrification Solution, VS)은 HEPES 용액, 수크로스(Sucrose), 에틸렌글리콜(Ethylene Glycol), DMSO(dimethyl sulphoxide) 및 SSS(또는 SPS)이 특정 비율로 혼합되어 형성된다. Vitrification Solution (VS) is formed by mixing HEPES solution, sucrose, ethylene glycol (Ethylene Glycol), dimethyl sulphoxide (DMSO), and SSS (or SPS) in a specific ratio.
본 발명에서, 조직(150)은 조직안착부(130)에 놓인 상태로 유리화용 메디아 중 하나인 균형용액(Equilibration Solution, ES)에서 25분동안 약품처리된 후, 멸균거즈를 이용하여 조직(150)에서 균형용액(Equilibration Solution, ES)을 제거한다. 이후, 조직(150)은 조직안착부(130)에 놓인 상태로, 유리화 용액(Vitrification Solution, VS)에서 15분동안 약품처리된다. 이후, 멸균거즈를 이용하여 조직(150)에서 유리화 용액이 제거된다. In the present invention, the tissue 150 is placed on the tissue seating unit 130 and treated with chemicals for 25 minutes in an Equilibration Solution (ES), which is one of the media for vitrification, and then the tissue 150 using sterile gauze. ) From the Equilibration Solution (ES). Thereafter, the tissue 150 is placed on the tissue seating unit 130 and is treated with chemicals for 15 minutes in a vitrification solution (VS). Thereafter, the vitrification solution is removed from the tissue 150 using sterile gauze.
다음으로, 조직안착부(130)가 액화질소통(160)의 내부로 삽입되어 액화질소통(160) 내의 액화질소에 의해 조직(150)이 급속동결되어 유리화된다. Next, the tissue seating unit 130 is inserted into the liquid nitrogen communication unit 160 and the tissue 150 is rapidly frozen and vitrified by the liquid nitrogen in the liquid nitrogen communication unit 160.
약품처리된 조직(150)은 조직안착부(130)에 놓인 상태 그대로 액화질소통(160)으로 삽입되어, 액화질소에 의해 유리화된다. 조직(150)의 유리화(vitrification) 과정은, 약품처리된 조직(150)이 액화질소통(160)의 액화질소에 감겨져 급속냉각되면서 조직(150)이 유리질 조직(150)으로 변화되는 과정이다. The chemically treated tissue 150 is inserted into the liquid nitrogen communication unit 160 as it is placed on the tissue seating unit 130, and is vitrified by the liquid nitrogen. The vitrification process of the tissue 150 is a process in which the chemically treated tissue 150 is wound in liquid nitrogen of the liquid nitrogen communication unit 160 and rapidly cooled, so that the tissue 150 is changed into a vitreous tissue 150.
이는, 작업자가 조직안착부(130)의 손잡이(131)를 잡고, 조직(150)만 액화질소에 담근 상태에서 조직안착부(130)를 살살 흔들면서 조직(150)의 전면적에 걸쳐 액화질소와 접촉되게 진행된다. 액화질소는 메쉬망(132)을 통해 조직안착부(130)로 유입된다. 조직(150)은 액화질소에 의해 급속냉각되면서 유리화된다. This is, while the operator grasps the handle 131 of the tissue seating unit 130, and gently shakes the tissue seating unit 130 while only the tissue 150 is immersed in liquid nitrogen, the liquid nitrogen and liquid nitrogen and Proceed to contact. Liquid nitrogen is introduced into the tissue seating unit 130 through the mesh network 132. The tissue 150 is vitrified while being rapidly cooled by liquid nitrogen.
이어서, 조직보관부(110)가 액화질소통(160)의 내부로 삽입된다. 그리고, 보관케이스(114)에 액화질소가 담긴다. 액화질소통(160) 내부에서, 조직안착부(130)가 보관케이스(114)로 삽입되어 거치된다. 이때, 조직(150)은 보관케이스(114)의 내부공간에서 액화질소에 잠긴다. Subsequently, the tissue storage unit 110 is inserted into the liquid nitrogen communication unit 160. Then, liquid nitrogen is contained in the storage case 114. Inside the liquid nitrogen communication 160, the tissue mounting portion 130 is inserted into the storage case 114 and mounted. At this time, the tissue 150 is immersed in liquid nitrogen in the inner space of the storage case 114.
이어서, 액화질소통(160) 내부에서, 작업자는 제2손잡이(113b1)를 아래로 누르는 간단한 방식으로, 보관뚜껑(115)을 조직보관케이스(114)에 결합한다. 이에, 본 발명은 액화질소가 담긴 보관케이스(114)를 손으로 잡지 않고도 조직보관부(110)를 밀봉하여, 종래에 문제점으로 지적되었던 조직안착부(130)를 액화질소가 저장된 보관케이스(114)에 밀봉하는 과정에서 빈번하게 발생되던, 액화질소와의 접촉에 의한 화상을 방지할 수 있다. Then, inside the liquid nitrogen communication 160, the operator couples the storage lid 115 to the tissue storage case 114 in a simple manner to press down the second handle 113b1. Accordingly, the present invention seals the tissue storage unit 110 without holding the storage case 114 containing liquid nitrogen by hand, so that the tissue seating unit 130, which has been pointed out as a problem in the prior art, is a storage case 114 in which liquid nitrogen is stored. ), which frequently occurs in the process of sealing, can prevent burns caused by contact with liquid nitrogen.
이후, 본 발명인 조직의 급속동결 보관장치(100)는 액화질소통(160)에서 나와, 디퍼에 거치된 후 동결보관탱크(180)에서 동결보관된다. 상술했듯이, 동결보관탱크(180)는 액화질소가 저장된 탱크로서, 탱크뚜껑에 의해 내부공간이 개폐된다. Thereafter, the inventors' tissue rapid freezing storage device 100 comes out of the liquid nitrogen communication unit 160, is mounted on a dipper, and stored frozen in a freezing storage tank 180. As described above, the freezing storage tank 180 is a tank in which liquid nitrogen is stored, and the inner space is opened and closed by the tank lid.
본 발명인 조직의 급속동결 보관장치(100)는 액화질소통(160) 밖으로 나와 상온에서 동결보관탱크(180)로 이동되는 과정에서, 조직(150)이 조직보관부(110)에 저장된 액화질소에 의해 조직(150)의 유리화가 유지되어, 종래기술에서 문제점으로 지적됐던 액화질소와 상온의 온도차이에 의한 조직(150)의 열변형을 방지할 수 있다. In the process of moving out of the liquid nitrogen communication 160 to the freezing storage tank 180 at room temperature, the tissue 150 is stored in the liquid nitrogen stored in the tissue storage unit 110. As a result, vitrification of the tissue 150 is maintained, and thermal deformation of the tissue 150 due to a temperature difference between liquid nitrogen and room temperature, which has been pointed out as a problem in the prior art, can be prevented.
결과적으로, 본 발명은 조직(150)의 동결과정에서 조직(150)의 손상을 방지함으로써, 추후 동결된 조직(150)을 해동하여 조직(150) 이식 수술을 수행하는 경우, 수술성과를 향상시킬 수 있다. As a result, the present invention prevents damage to the tissue 150 during the freezing process of the tissue 150, so that when a tissue 150 transplantation surgery is performed by defrosting the frozen tissue 150 later, the surgical performance can be improved. I can.
비록 본 발명의 몇몇 실시예들이 도시되고 설명되었지만, 본 발명이 속하는 기술분야의 통상의 지식을 가진 당업자라면 본 발명의 원칙이나 정신에서 벗어나지 않으면서 본 실시예를 변형할 수 있음을 알 수 있을 것이다. 발명의 범위는 첨부된 청구항과 그 균등물에 의해 정해질 것이다.Although some embodiments of the present invention have been shown and described, those skilled in the art of ordinary skill in the art to which the present invention pertains will appreciate that the present embodiments can be modified without departing from the principles or spirit of the present invention. . The scope of the invention will be determined by the appended claims and their equivalents.
[부호의 설명][Explanation of code]
100: 조직의 급속동결 보관장치100: tissue fast freezing storage device
110: 조직보관부 111: 케이스거치부110: organizational storage unit 111: case holding unit
112: 뚜껑거치부 113: 조작부재112: lid holder 113: operation member
114: 보관케이스 115: 보관뚜껑114: storage case 115: storage lid
130: 조직안착부 160: 액화질소통130: tissue seating unit 160: liquid nitrogen communication
170: 디퍼 180: 동결보관탱크170: dipper 180: freezing storage tank
본 발명은 난소 등과 같은 조직의 동결 보관 분야에 적용 가능하다.The present invention is applicable to the field of frozen storage of tissues such as ovaries.

Claims (9)

  1. 상부가 개방된 통형상을 가지며, 조직이 놓이는 조직안착부; 및The upper portion has an open cylindrical shape, the tissue seating portion on which the tissue is placed; And
    상부가 개방된 통형상을 가지며 상기 조직안착부가 거치되는 보관케이스와, 상기 보관케이스의 내부공간을 밀봉하는 보관뚜껑과, 상기 보관뚜껑이 상기 보관케이스에 대해 상하방향으로 이동되면서 상기 보관뚜껑이 상기 보관케이스에 결합되게 상기 보관뚜껑의 이동을 조작하는 조작부재를 포함하는 조직보관부를 포함하되, A storage case having an open top and a storage case in which the tissue mounting part is mounted, a storage lid sealing the inner space of the storage case, and the storage lid as the storage lid is moved up and down with respect to the storage case. Including a tissue storage unit including an operation member for operating the movement of the storage lid to be coupled to the storage case,
    상기 조직은 상기 조직안착부에 놓여 액화질소통의 내부에서 액화질소에 의해 유리화되고, The tissue is placed on the tissue seat and is vitrified by liquid nitrogen in the liquid nitrogen communication,
    유리화된 조직은 상기 액화질소통 내부에서 상기 조직안착부가 액화질소가 담긴 상기 보관케이스로 삽입된 후, 상기 조작부재의 조작에 의해 상기 보관뚜껑이 상기 보관케이스에 결합됨에 따라, 상기 보관케이스에 담겨진 상기 액화질소에 의해 유리화가 지속되게 상기 조직보관부에 동결보관되는 것을 특징으로 하는 조직의 급속동결 보관장치. The vitrified tissue is contained in the storage case as the tissue seating portion is inserted into the storage case containing liquid nitrogen in the liquid nitrogen communication container, and then the storage lid is coupled to the storage case by operation of the operation member. Rapid freezing storage apparatus for tissues, characterized in that frozen storage in the tissue storage unit to continue vitrification by the liquid nitrogen.
  2. 제 1 항에 있어서, The method of claim 1,
    상기 조작부재는 상기 보관케이스에 설치된 제1조작부재와, 상기 보관뚜껑에 설치된 제2조작부재를 포함하고, The operating member includes a first operating member installed on the storage case, and a second operating member installed on the storage lid,
    상기 제2조작부재는 상기 보관케이스와 상기 보관뚜껑이 상하 배치되게 상기 제1조작부재에 결합되고, 상기 제1조작부재를 따라 하부로 이동되면서 상기 보관뚜껑을 상기 보관케이스에 결합되도록 작동되는 것을 특징으로 하는 조직의 급속동결 보관장치.The second operation member is coupled to the first operation member so that the storage case and the storage lid are arranged vertically, and is operated to couple the storage lid to the storage case while moving downward along the first operation member. Rapid freezing storage device for tissues characterized by.
  3. 제 1 항에 있어서, 상기 조직보관부는, The method of claim 1, wherein the tissue storage unit,
    상기 보관케이스가 거치되는 케이스거치부와, A case holder on which the storage case is mounted,
    상기 케이스거치부의 상부에서 상기 케이스거치부와 마주보게 위치되고 상기 보관뚜껑이 거치되는 뚜껑거치부를 더 포함하고, Further comprising a lid holder positioned at the top of the case holder to face the case holder and on which the storage lid is mounted,
    상기 조작부재는 상기 뚜껑거치부와 상기 케이스거치부를 연결하여 상기 케이스거치부와 상기 뚜껑거치부 간의 간격을 조작하는 것을 특징으로 하는 조직의 급속동결 보관장치. The operation member connects the lid holder and the case holder to manipulate a gap between the case holder and the lid holder.
  4. 제 1 항에 있어서, The method of claim 1,
    상기 조직안착부는 바닥면이 메쉬망으로 이루어져, The tissue seating portion is made of a mesh net at the bottom,
    상기 조직이 유리화되기 전, 유리화용 메디아에 의해 약품처리될 때, Before the tissue is vitrified, when chemically treated by the vitrification media,
    상기 조직안착부가 상기 조직이 안착된 상태로, 상기 유리화용 메디아가 담긴 약품용기로 삽입되어 상기 유리화용 메디아에 담겨져 약품처리되는 것을 특징으로 하는 조직의 급속동결 보관장치.The tissue seating unit is inserted into a medicine container containing the vitrification media in a state in which the tissue is seated, and is contained in the vitrification media to be treated with chemicals.
  5. 제 4 항에 있어서, The method of claim 4,
    상기 조직안착부는 바닥면이 열전도율이 높은 재질로 이루어진 것을 특징으로 하는 조직의 급속동결 보관장치. The tissue seating unit, characterized in that the bottom surface is made of a material having high thermal conductivity.
  6. (A) 조직이 조직안착부에 놓인 상태로, 유리화용 메디아에 의해 약품처리되는 단계; (A) in a state in which the tissue is placed on the tissue seating portion, the step of chemical treatment by the media for vitrification;
    (B) 상기 조직안착부가 액화질소통의 내부로 삽입되어 상기 액화질소통 내의 액화질소에 의해 상기 조직이 급속동결되어 유리화되는 단계; (B) a step in which the tissue seating portion is inserted into the liquid nitrogen communication and the tissue is rapidly frozen and vitrified by the liquid nitrogen in the liquid nitrogen communication;
    (C) 보관케이스, 보관뚜껑 및 조작부재를 포함하는 조직보관부가 상기 액화질소통의 내부로 삽입되고, 상기 보관케이스에 상기 액화질소가 담기는 단계; (C) inserting a tissue storage unit including a storage case, a storage lid and an operating member into the liquid nitrogen communication unit, and containing the liquid nitrogen in the storage case;
    (D) 상기 조직안착부가 상기 보관케이스로 삽입되어 거치되어, 상기 조직이 상기 보관케이스의 내부공간에서 상기 액화질소에 잠기는 단계; (D) the tissue seating portion is inserted into the storage case and mounted so that the tissue is immersed in the liquid nitrogen in the inner space of the storage case;
    (E) 상기 조작부재에 의해 상기 보관뚜껑이 상기 보관케이스에 결합되게 작동되어, 상기 조직이 상기 내부공간의 상기 액화질소에 담겨진 상태로 밀봉하는 단계; 및(E) a step of sealing the tissue in a state immersed in the liquid nitrogen in the inner space by operating the storage lid to be coupled to the storage case by the operation member; And
    (F) 상기 조직보관부가 상기 보관케이스 내의 상기 액화질소에 의해 냉기가 유지된 상태로, 상기 액화질소통 밖으로 나와 동결보관탱크로 삽입되어, 상기 동결보관탱크에서 조직보관되는 단계를 포함하는 것을 특징으로 하는 조직의 급속동결 보관방법. (F) the tissue storage unit in a state in which cold air is maintained by the liquid nitrogen in the storage case, and is inserted out of the liquid nitrogen communication and inserted into a freezing storage tank, and storing tissue in the freezing storage tank. Fast freezing storage method of tissue
  7. 제 6 항에 있어서, The method of claim 6,
    상기 B 단계 내지 상기 E단계는 상기 액화질소통에서 순차적으로 진행되는 것을 특징으로 하는 조직의 급속동결 보관방법. The step B to the step E is a rapid freezing storage method of the tissue, characterized in that it proceeds sequentially in the liquid nitrogen communication.
  8. 제 7 항에 있어서, The method of claim 7,
    상기 F단계에서, 상기 조직보관부는 상기 동결보관탱크에 거치되는 디퍼에 안착되어, 상기 동결보관탱크 내의 액화질소에 잠기게 위치되는 것을 특징으로 하는 조직의 급속동결 보관방법.In the step F, the tissue storage unit is mounted on a dipper mounted on the freezing storage tank, and is positioned to be immersed in liquid nitrogen in the freezing storage tank.
  9. 제 6 항에 있어서, The method of claim 6,
    상기 조직안착부는 바닥면이 메쉬망으로 이루어져, The tissue seating portion is made of a mesh net at the bottom,
    상기 조직이 유리화되기 전 상기 유리화용 메디아에 의해 약품처리될 때, When the tissue is chemically treated by the vitrification media before vitrification,
    상기 조직안착부가 상기 조직이 안착된 상태로, 상기 유리화용 메디아가 담긴 약품용기로 삽입되어 상기 유리화용 메디아에 담겨져 약품처리되는 것을 특징으로 하는 조직의 급속동결 보관방법.The tissue seating portion is inserted into a medicine container containing the vitrification media in a state in which the tissue is seated, and is contained in the vitrification media to be treated with chemicals.
PCT/KR2020/002948 2019-03-04 2020-03-02 Rapid-freezing storage device for tissue and rapid-freezing storage method for tissue WO2020180067A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2019-0024504 2019-03-04
KR1020190024504A KR102146379B1 (en) 2019-03-04 2019-03-04 Apparatus for management of cryopreserved cells and method thereof

Publications (1)

Publication Number Publication Date
WO2020180067A1 true WO2020180067A1 (en) 2020-09-10

Family

ID=72235500

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2020/002948 WO2020180067A1 (en) 2019-03-04 2020-03-02 Rapid-freezing storage device for tissue and rapid-freezing storage method for tissue

Country Status (2)

Country Link
KR (1) KR102146379B1 (en)
WO (1) WO2020180067A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112385644A (en) * 2020-11-16 2021-02-23 吴昌育 Biological cell bin for genetic engineering
CN114291393A (en) * 2022-01-26 2022-04-08 保食链食品科技江苏有限公司 Biological sample quality-guaranteeing storage and transportation device for genetic engineering

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100270929B1 (en) * 1998-05-19 2000-11-01 김강권 A freezing composite and a freezing method of immaturity yolk and thawing method
KR200427773Y1 (en) * 2006-07-10 2006-09-29 서성교 A safety cane for sample tube of ultra cold freezer
KR100779812B1 (en) * 2001-09-14 2007-11-28 사이토리 테라퓨틱스, 인크. Preservation of non embryonic cells from non hematopoietic tissues
JP2008285181A (en) * 2007-05-16 2008-11-27 Taiyo Nippon Sanso Corp Freezing storage container
JP2016519682A (en) * 2013-04-09 2016-07-07 ロウ,ウェイ Vitrification freezing carrier of biological sample and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5825571B2 (en) 1975-10-23 1983-05-28 日立化成工業株式会社 Netsukou Kaseiji Yushisei Keizai Ryouno Seizouhouhou
JP2019097976A (en) * 2017-12-05 2019-06-24 大陽日酸株式会社 Cryopreservation device and automated system including the device
JP2019180306A (en) * 2018-04-11 2019-10-24 株式会社北里コーポレーション Canister for living body cell freezing and storage tool for living body cell freezing

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100270929B1 (en) * 1998-05-19 2000-11-01 김강권 A freezing composite and a freezing method of immaturity yolk and thawing method
KR100779812B1 (en) * 2001-09-14 2007-11-28 사이토리 테라퓨틱스, 인크. Preservation of non embryonic cells from non hematopoietic tissues
KR200427773Y1 (en) * 2006-07-10 2006-09-29 서성교 A safety cane for sample tube of ultra cold freezer
JP2008285181A (en) * 2007-05-16 2008-11-27 Taiyo Nippon Sanso Corp Freezing storage container
JP2016519682A (en) * 2013-04-09 2016-07-07 ロウ,ウェイ Vitrification freezing carrier of biological sample and use thereof

Also Published As

Publication number Publication date
KR102146379B1 (en) 2020-08-21

Similar Documents

Publication Publication Date Title
Cohen et al. Pregnancies following the frozen storage of expanding human blastocysts
WO2020180067A1 (en) Rapid-freezing storage device for tissue and rapid-freezing storage method for tissue
Antinori et al. Cryotop vitrification of human oocytes results in high survival rate and healthy deliveries
Schlegel et al. Testicular sperm extraction with intracytoplasmic sperm injection for nonobstructive azoospermia
Aigner et al. The influence of slow and ultra-rapid freezing on the organization of the meiotic spindle of the mouse oocyte
Karlsson et al. Fertilization and development of mouse oocytes cryopreserved using a theoretically optimized protocol
Tucker et al. Partial dissection of the zona pellucida of frozen-thawed e human embryos may enhance blastocyst hatching, implantation, and pregnancy rates
Outi et al. Testicular needle biopsy, open biopsy, epididymal aspiration and intracytoplasmic sperm injection in obstructive azoospermia
US7781207B2 (en) In vitro fertilisation
Hsieh et al. Cryopreservation of human spermatozoa within human or mouse empty zona pellucidae
Tucker et al. Human oocyte cryopreservation: a valid alternative to embryo cryopreservation?
Quinn et al. Experience with the cryopreservation of human embryos using the mouse as a model to establish successful techniques
Van Steirteghem et al. Cryopreservation of human embryos obtained after gamete intra-Fallopian transfer and/or in-vitro fertilization
Gook et al. Cryopreservation of female reproductive potential
CN201222947Y (en) Needling type carrier for vitrification of tissue piece
JP2007508025A (en) Laboratory equipment with two cabinets
Bernabeu et al. Successful pregnancy after spermatid injection.
Shu et al. Pregnancy and live birth following the transfer of vitrified–warmed blastocysts derived from zona-and corona-cell-free oocytes
Naitana et al. Effect of biopsy and vitrification on in vitro survival of ovine embryos at different stages of development
Maltaris et al. Comparison of xenografting in SCID mice and LIVE/DEAD assay as a predictor of the developmental potential of cryopreserved ovarian tissue
Bielanski et al. Factors affecting survival of deep frozen bovine embryos in vitro: the effect of freezing container and method of removing cryoprotectant
Sokoloski et al. Laboratory details in an in vitro fertilization and embryo transfer program
Cedars Embryo cryopreservation
KR20170050930A (en) Device for ovarian tissue vitrification
McCaffrey et al. General Insemination for IVF

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20767265

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20767265

Country of ref document: EP

Kind code of ref document: A1